April 17 (Reuters) - Canada’s main stock index rose on Friday, as reports of a potential drug to treat COVID-19 heightened demand for riskier assets, while U.S. President Donald Trump’s plan to gradually reopen the country’s economy added to the bounce.
* At 9:33 a.m. ET (1333 GMT), the Toronto Stock Exchange’s S&P/TSX composite index was up 235.86 points, or 1.7%, at 14,135.18. (Reporting by Shreyashi Sanyal in Bengaluru; Editing by Shounak Dasgupta)
Our Standards: The Thomson Reuters Trust Principles.